glucagon has been researched along with alprostadil in 32 studies
Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (alprostadil) | Trials (alprostadil) | Recent Studies (post-2010) (alprostadil) |
---|---|---|---|---|---|
26,039 | 1,498 | 3,054 | 7,136 | 864 | 761 |
Protein | Taxonomy | glucagon (IC50) | alprostadil (IC50) |
---|---|---|---|
Multidrug resistance-associated protein 4 | Homo sapiens (human) | 2.3 | |
Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.0358 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (65.63) | 18.7374 |
1990's | 10 (31.25) | 18.2507 |
2000's | 1 (3.13) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukui, H; Kikuchi, E; Kitano, H; Matsumoto, M; Morimura, M; Nakano, H; Okamoto, Y; Tsujii, T | 1 |
Boege, F; Cantrill, RC; Hahn, M; Heithier, H; Kurstjens, NP | 1 |
Abyholm, T; Bjørnerheim, R; Hansson, V; Tanbo, T | 1 |
Christoffersen, T; Gladhaug, IP; Melien, O; Refsnes, M; Winsnes, R | 1 |
Iyengar, R; Premont, RT | 1 |
Cushman, SW; Honnor, RC; Kuroda, M; Londos, C; Simpson, IA | 1 |
Saggerson, ED | 1 |
Barka, T; Shaw, PA; van der Noen, H | 1 |
Okumura, T; Sago, T; Saito, K | 1 |
Iguchi, A; Matsunaga, H; Niki, I; Sakamoto, N; Yanagisawa, S; Yatomi, A | 1 |
Hansson, V; Jahnsen, T; Smith, AJ | 1 |
Hayashi, O; Imura, H; Nishi, S; Seino, S; Seino, Y; Shimizu, T; Takemura, J; Tsuda, K | 1 |
Devis, PE; Grohol, SH; Taub, M | 1 |
Kobayashi, R; Kumegawa, M; Maeda, N; Mizunuma, H; Shima, H; Tanaka, S; Tashima, Y | 1 |
Johnson, RA | 1 |
Chader, GJ; Koh, SW | 1 |
Ganguli, S; Sinha, M; Sperling, MA | 1 |
Alonso de Armiño, V; Carbonell, I; Frasquet, I; García-Casarrubios, A | 1 |
Masui, H; Murakami, H; Raschke, WC; Sato, G | 1 |
Codina, J; Floyd, G; Hildebrandt, JD; Iyengar, R; Rich, KA; Sekura, R | 1 |
Attramadal, H; Erichsen, A; Hansson, V; Jahnsen, T | 1 |
Brass, EP; Garrity, MJ; Robertson, RP | 1 |
Hirayama, A; Moriya, H; Shimoyama, R | 1 |
Granger, DN; Kvietys, PR; Perry, MA; Taylor, AE | 1 |
Ohtsu, S; Oishi, S; Okuda, C; Sakio, H; Tanaka, Y; Ueno, K | 1 |
Abei, M; Chiba, T; Ikegami, T; Kurusu, J; Matsuzaki, Y; Osuga, T; Saito, Y; Shoda, J; Tanaka, N; Yoshiga, S | 1 |
Houslay, MD; Livingstone, C; MacDonald, C; Willett, B | 1 |
Chiba, S; Haba, Y; Hanazaki, K; Homma, T; Iwatsuki, K; Kuroda, T; Shiohara, E | 1 |
Haba, Y; Hanazaki, K; Iida, F; Kajikawa, S; Kuroda, T; Shiohara, E | 1 |
Kato, M; Moriwaki, H; Murase, M; Muto, Y | 1 |
Abe, T; Abei, M; Chiba, T; Ikegami, T; Matsuzaki, Y; Nishi, M; Osuga, T; Sato, Y; Tanaka, N; Tomida, S | 1 |
Baraldi, L; Bianchi, G; Brizi, M; Forlani, G; Marchesini, G; Melchionda, N; Natale, S; Zaccheroni, V | 1 |
1 review(s) available for glucagon and alprostadil
Article | Year |
---|---|
Severe acute hepatitis A associated with acute pure red cell aplasia.
Topics: Acute Disease; Alprostadil; Biopsy; Combined Modality Therapy; Gastrointestinal Agents; Glucagon; Hepatitis A; Humans; Insulin; Liver; Male; Middle Aged; Plasma Exchange; Red-Cell Aplasia, Pure | 1996 |
2 trial(s) available for glucagon and alprostadil
Article | Year |
---|---|
Randomized control trial of lipo-prostaglandin E1 in patients with acute liver injury induced by lipiodol-targeted chemotherapy.
Topics: Aged; Alprostadil; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Glucagon; Humans; Injections, Intravenous; Insulin; Iodized Oil; Liver Failure; Liver Function Tests; Liver Neoplasms; Male; Middle Aged | 1995 |
Systemic prostaglandin E1 infusion and hepatic aminonitrogen to urea nitrogen conversion in patients with type 2 diabetes in poor metabolic control.
Topics: Aged; Alanine; Alprostadil; Anthropometry; Blood Glucose; Diabetes Mellitus, Type 2; Glucagon; Humans; Infusions, Intravenous; Insulin; Liver; Male; Middle Aged; Nitrogen; Time Factors; Urea | 2001 |
29 other study(ies) available for glucagon and alprostadil
Article | Year |
---|---|
D-galactosamine-induced cell damage enhances specific binding of prostaglandin E1 to rat hepatocytes.
Topics: Alprostadil; Animals; Binding Sites; Binding, Competitive; Carbon Tetrachloride; Cells, Cultured; Cycloheximide; Dactinomycin; Galactosamine; Glucagon; Kinetics; Linoleic Acid; Linoleic Acids; Liver; Male; Norepinephrine; Palmitic Acid; Palmitic Acids; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Prostaglandin E | 1992 |
Multiple hormone actions: the rises in cAMP and Ca++ in MDCK-cells treated with glucagon and prostaglandin E1 are independent processes.
Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Animals; Calcium; Carbachol; Cell Line; Colforsin; Cyclic AMP; Dogs; Fluorescent Dyes; Glucagon; Indoles; Isoproterenol; Kidney; Kinetics; Receptors, Gastrointestinal Hormone; Receptors, Glucagon | 1990 |
Hormone-responsive adenylyl cyclase in the human fallopian tube.
Topics: Adenylyl Cyclases; Alprostadil; Chorionic Gonadotropin; Dinoprost; Dinoprostone; Fallopian Tubes; Female; Follicle Stimulating Hormone; Glucagon; Hormones; Humans; Isoproterenol; Kinetics; Terbutaline; Vasoactive Intestinal Peptide | 1991 |
Pertussis toxin abolishes the inhibitory effects of prostaglandins E1, E2, I2 and F2 alpha on hormone-induced cAMP accumulation in cultured hepatocytes.
Topics: Adenylate Cyclase Toxin; Alprostadil; Animals; Cells, Cultured; Cyclic AMP; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Epoprostenol; Glucagon; Isoproterenol; Liver; Male; Pertussis Toxin; Prostaglandins E; Prostaglandins F; Rats; Rats, Inbred Strains; Virulence Factors, Bordetella | 1988 |
Glucagon-induced desensitization of adenylyl cyclase in primary cultures of chick hepatocytes. Evidence for multiple pathways.
Topics: Adenylyl Cyclases; Alprostadil; Angiotensin II; Animals; Cells, Cultured; Chickens; Cycloheximide; Glucagon; Isoproterenol; Kinetics; Liver; Receptors, Gastrointestinal Hormone; Receptors, Glucagon; Tetradecanoylphorbol Acetate; Vasopressins | 1988 |
Regulation of insulin-stimulated glucose transport in the isolated rat adipocyte. cAMP-independent effects of lipolytic and antilipolytic agents.
Topics: 3-O-Methylglucose; Adenosine; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adipose Tissue; Adrenocorticotropic Hormone; Alprostadil; Animals; Biological Transport; Bucladesine; Cyclic AMP; Glucagon; Glucose; Insulin; Isoproterenol; Lipolysis; Male; Methylglucosides; Niacin; Phenylisopropyladenosine; Protein Kinases; Rats | 1987 |
Sensitivity of adipocyte lipolysis to stimulatory and inhibitory agonists in hypothyroidism and starvation.
Topics: Adenosine Deaminase; Adipose Tissue; Adrenocorticotropic Hormone; Alprostadil; Animals; Glucagon; Hypothyroidism; In Vitro Techniques; Lipolysis; Niacin; Norepinephrine; Pertussis Toxin; Phenylisopropyladenosine; Rats; Starvation; Virulence Factors, Bordetella | 1986 |
Proto-oncogene fos (c-fos) expression in the heart.
Topics: Alprostadil; Animals; Calcium Channel Blockers; Cricetinae; Gene Expression Regulation; Glucagon; Heart; Histamine; Mice; Proto-Oncogene Proteins; Proto-Oncogenes; Rats; RNA, Messenger; Sympathomimetics | 1987 |
Effect of prostaglandins and their analogues on hormone-stimulated glycogenolysis in primary cultures of rat hepatocytes.
Topics: 16,16-Dimethylprostaglandin E2; Alprostadil; Animals; Cells, Cultured; Dinoprostone; Epinephrine; Glucagon; Glucose; Isoproterenol; Liver Glycogen; Male; Propranolol; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred Strains; Time Factors | 1988 |
Prostaglandins affect the central nervous system to produce hyperglycemia in rats.
Topics: Alprostadil; Animals; Blood Glucose; Body Temperature; Central Nervous System; Dinoprost; Dinoprostone; Epinephrine; Glucagon; Hepatic Veins; Injections, Intraventricular; Male; Norepinephrine; Prostaglandin D2; Prostaglandins; Prostaglandins D; Prostaglandins E; Prostaglandins F; Rats; Rats, Inbred Strains | 1987 |
Membrane-bound adenylate cyclase activity in the testis of the blue fox.
Topics: Adenylyl Cyclases; Alprostadil; Animals; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Follicle Stimulating Hormone; Foxes; Glucagon; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Isoproterenol; Magnesium; Male; Manganese; Membranes; Testis; Time Factors | 1985 |
Different effects of prostaglandin E1, E2 and D2 on pancreatic somatostatin release.
Topics: Alprostadil; Animals; Dinoprostone; Glucagon; Insulin; Male; Pancreas; Perfusion; Prostaglandin D2; Prostaglandins D; Prostaglandins E; Rats; Rats, Inbred Strains; Somatostatin | 1984 |
PGE1-independent MDCK cells have elevated intracellular cyclic AMP but retain the growth stimulatory effects of glucagon and epidermal growth factor in serum-free medium.
Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Animals; Bucladesine; Cell Division; Cell Line; Culture Media; Cyclic AMP; Dogs; Epidermal Growth Factor; Glucagon; Kidney; Prostaglandins E | 1984 |
Induction of fructose 1,6-bisphosphatase and glucose 6-phosphatase by dibutyryl cyclic adenosine monophosphate in fetal mouse liver.
Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Animals; Bucladesine; Butyrates; Butyric Acid; Enzyme Induction; Female; Fetus; Fructose-Bisphosphatase; Glucagon; Glucose-6-Phosphatase; Hormones; Isoproterenol; Kinetics; Liver; Mice; Mice, Inbred ICR; Organ Culture Techniques; Pregnancy; Prostaglandins E | 1984 |
Mn2+ does not uncouple adenosine "Ra" receptors from the liver adenylate cyclase.
Topics: Adenosine; Adenylyl Cyclases; Alprostadil; Animals; Cell Membrane; Glucagon; Kinetics; Liver; Manganese; Prostaglandins E; Rats; Receptors, Cell Surface; Receptors, Purinergic; Sodium Fluoride | 1982 |
Agonist effects on the intracellular cyclic AMP concentration of retinal pigment epithelial cells in culture.
Topics: Alprostadil; Animals; Cells, Cultured; Chick Embryo; Cyclic AMP; Glucagon; Histamine; Isoproterenol; Pigment Epithelium of Eye; Prostaglandins E; Thyrotropin; Vasoactive Intestinal Peptide | 1984 |
Ontogeny of insulin and glucagon receptors and the adenylate cyclase system in guinea pig liver.
Topics: Adenylyl Cyclases; Alprostadil; Animals; Animals, Newborn; Cell Membrane; Cholera Toxin; Cyclic AMP; Female; Glucagon; Guinea Pigs; Liver; Prostaglandins E; Receptor, Insulin; Receptors, Cell Surface; Receptors, Glucagon; Sodium Fluoride | 1984 |
[Pancreatic secretion in rats treated with intra-aortic prostaglandin E1].
Topics: Alprostadil; Animals; Aorta, Abdominal; Blood Glucose; Glucagon; Indomethacin; Injections, Intra-Arterial; Insulin; Insulin Secretion; Islets of Langerhans; Male; Prostaglandin Antagonists; Prostaglandins E; Rats; Rats, Inbred Strains | 1983 |
Growth of mouse plasmacytoma cells in serum-free, hormone-supplemented medium: procedure for the determination of hormone and growth factor requirements for cell growth.
Topics: Alprostadil; Animals; Cell Division; Cell Line; Epidermal Growth Factor; Fibroblast Growth Factors; Glucagon; Gonadotropin-Releasing Hormone; Growth Substances; Hormones; Immunoglobulins; Luteinizing Hormone; Mice; Neoplasms, Experimental; Nerve Growth Factors; Peptides; Plasmacytoma; Prostaglandins E; Transferrin | 1981 |
Glucagon-induced heterologous desensitization of the MDCK cell adenylyl cyclase. Increases in the apparent levels of the inhibitory regulator (Ni).
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Alprostadil; Animals; Bacterial Toxins; Cell Line; Dogs; Dose-Response Relationship, Drug; Glucagon; Kidney; Macromolecular Substances; Pertussis Toxin; Prostaglandins E; Sodium Fluoride; Time Factors; Virulence Factors, Bordetella | 1984 |
A transplantable rat Leydig cell tumor--2. Adenylyl cyclase activation by prostaglandin E1, isoproterenol and glucagon.
Topics: Adenylyl Cyclases; Alprostadil; Animals; Dose-Response Relationship, Drug; Enzyme Activation; Glucagon; Isoproterenol; Leydig Cell Tumor; Male; Neoplasm Transplantation; Prostaglandins E; Rats; Testicular Neoplasms | 1984 |
Inhibition of glucagon-stimulated hepatic glycogenolysis by E-series prostaglandins.
Topics: Alprostadil; Animals; Dinoprostone; Glucagon; Liver; Liver Glycogen; Male; Perfusion; Prostaglandins E; Prostaglandins E, Synthetic; Rats; Rats, Inbred Strains | 1984 |
Prostaglandin E1-induced glucagon secretion under propranolol treatment in a case of idiopathic hyperglucagonemia.
Topics: Adult; Alprostadil; Female; Glucagon; Humans; Infusions, Intra-Arterial; Insulin; Propranolol; Prostaglandins E | 1982 |
Relationship between intestinal volume secretion and oxygen uptake.
Topics: Alprostadil; Animals; Cats; Cholera Toxin; Glucagon; Histamine; Ileum; Intestinal Secretions; Oxygen Consumption; Prostaglandins E; Ricinoleic Acids; Secretory Rate; Theophylline; Vasoactive Intestinal Peptide | 1982 |
[How should we treat intestinal ischemia?--II: Effects of pentoxifylline, glucagon and prostaglandin E1].
Topics: Alprostadil; Animals; Dogs; Glucagon; Hydrogen-Ion Concentration; Intestinal Mucosa; Intestines; Ischemia; Mesenteric Artery, Superior; Oxygen Consumption; Pentoxifylline; Regional Blood Flow | 1995 |
Analysis of the adenylate cyclase signalling system, and alterations induced by culture with insulin, in a novel SV40-DNA-immortalized hepatocyte cell line (P9 cells).
Topics: Adenosine Diphosphate Ribose; Adenylyl Cyclases; Alprostadil; Animals; Cell Line; Cell Transformation, Viral; Colforsin; Glucagon; GTP-Binding Proteins; Guanosine Triphosphate; Insulin; Liver; Male; Rats; Rats, Sprague-Dawley; Receptor, Insulin; Signal Transduction | 1994 |
Prostaglandin E1 protects dog pancreas from ischemia-reperfusion injury.
Topics: 6-Ketoprostaglandin F1 alpha; Alprostadil; Animals; Dogs; Female; Glucagon; Insulin; Lipid Peroxides; Male; Pancreas; Reperfusion Injury; Thromboxane B2 | 1994 |
Prostaglandin E1 protects liver from ischemic damage.
Topics: Alprostadil; Analysis of Variance; Animals; Blood Glucose; Dogs; Female; Glucagon; Infusions, Intravenous; Insulin; Ischemia; Lipid Peroxides; Liver; Male; Reperfusion | 1994 |
[Recent advances in the treatment of decompensated liver cirrhosis].
Topics: Albumins; Alprostadil; Amino Acids, Branched-Chain; Diuretics; Glucagon; Hepatic Encephalopathy; Humans; Insulin; Jaundice; Lactulose; Liver Cirrhosis | 1994 |